Review Article
Emerging Trends in the Delivery of Resveratrol by Nanostructures: Applications of Nanotechnology in Life Sciences
Table 2
Nanoparticle-based systems reported for resveratrol.
| Type of nanoparticulate systems | Drug/s | Disease targeted | References |
| Chitosan-coated NPs | Resveratrol | Lung cancer | [119] | Alginate NPs | Curcumin and resveratrol | Prostate cancer | [120] | Gelatin-coated NPs | Resveratrol | Lung cancer | [121] | Mesoporous silica NPs | Resveratrol | Melanoma | [122] | Solid lipid NPs | Resveratrol | Contact dermatitis | [123] | Oxidized mesoporous carbon NPs | Resveratrol | Triple negative breast cancer | [124] | Super paramagnetic iron oxide NPs | Resveratrol | Glioma | [125] | Solid lipid NPs | Curcumin and resveratrol | Colorectal cancer | [126] | Solid-lipid microparticulate | Resveratrol | Melanoma | [127] | Lipid-core nanocapsules | Curcumin and resveratrol | Human skin disease | [128] | Galactosylated NPs | Resveratrol | Anti-inflammatory | [129] | PEG-PLGA NPs | Resveratrol | Liver cancer | [130] | Hyaluronic acid-functionalized chitosan nanoparticles | Curcumin and resveratrol | Diabetic wound | [131] | Poly (D,L-lactide-co-glycolide)-D-α-tocopheryl polyethylene glycol 1000 succinate blend NPs | Resveratrol | Glioma | [132] | Silk fibrin-coated NPs | Resveratrol | Inflammatory bowel disease | [133] | Mesoporous silica nanoparticles (MSNPs) | Anti-miR21 and resveratrol | Gastric carcinoma | [134] | Hepatic-targeted oxidized starch-lysozyme (OSL) nanocarriers | Resveratrol | Nonalcoholic fatty liver disease | [135] | Ethanol extract of Angelica gigas Nakai- (AGN Ex-) based NPs | Resveratrol | Ovarian cancer | [136] | Glyceryl behenate or polyoxyethylene 40 stearate-based lipid carriers | Resveratrol | Hyperpigmentation and melanogenesis | [137] | Chitosan-coated SLNs | Resveratrol (RSV) and ferulic acid | Colon cancer | [138] | Technetium-99 m labeled gold NPs | Resveratrol | Colon cancer | [139] | Polyethylene glycol-polylactic acid (PEG–PLA; M.W. 5000-5000) polymer NPs | Resveratrol | Colon cancer | [140] | Solid lipid NPs | Omega-3 PUFA and resveratrol | Colon cancer | [141] |
|
|